Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
HCMV UL38 and AKT Inactivation via IRS1
2026-08-22
The reference study proposes that human cytomegalovirus (HCMV) suppresses serum-responsive AKT not by directly blocking AKT, but by using UL38 to activate mTORC1 and destabilize insulin receptor substrate proteins. This mechanism links viral control of host protein synthesis with a cell-intrinsic feedback loop that prevents PI3K-dependent AKT membrane recruitment.
-
TCEP Hydrochloride for Protein and LFA Workflows
2026-08-21
TCEP hydrochloride combines odorless, water-soluble disulfide reduction with practical protein-preparation flexibility. This article connects protein digestion, structural mass spectrometry, and bioconjugation controls to the capture-and-release logic of a sensitivity-enhanced lateral flow assay.
-
Prochlorperazine: D2 Antagonist, Better Assays
2026-08-20
Prochlorperazine is a dopamine D2 receptor antagonist whose clinical adverse effects reveal important lessons for experimental design. This article connects a documented hemidystonia stroke mimic with melanoma research, antiviral mechanism studies, and practical assay controls.
-
Isradipine (Dynacirc): From L-Type Blockade to Translation
2026-08-20
Isradipine (Dynacirc) offers translational researchers a defined way to interrogate L-type calcium signaling across vascular and neuronal systems. By combining mechanistic pharmacology with the selectivity lessons of the v-agatoxin-IVA literature, this article presents a strategy for validating target engagement, interpreting neuroprotective phenotypes, and avoiding overextended conclusions in hypertension and neurodegenerative disease models.
-
Cytochalasin D: Actin Polymerization Inhibitor
2026-08-19
Cytochalasin D is an actin polymerization inhibitor that disrupts actin microfilaments and alters cytoskeletal processes. Product information reports a 25 nM IC50, while peer-reviewed corneal nanoparticle research supports a carefully limited use of cytoskeletal perturbation in cellular uptake studies.
-
Peptidisc-Assisted Nanobody Multimerization
2026-08-19
Chen and Duong van Hoa describe a peptidisc-assisted strategy that uses transmembrane-domain hydrophobicity to assemble nanobodies into water-soluble multimeric complexes called polybodies. The resulting assemblies improved avidity toward GFP and human serum albumin targets and supported bispecific and autofluorescent designs, expanding protein-engineering options beyond tandem fusion and conventional self-assembly scaffolds.
-
Epinephrine Bitartrate: Applied Research Workflows
2026-08-18
Build reproducible α- and β-adrenergic assays with Epinephrine Bitartrate, from concentration-response experiments to translational vasopressor modeling. This guide combines formulation control, time-resolved readouts, and lessons from the ARAMIS conversion-ratio study to improve assay interpretation without treating different vasoactive agents as interchangeable.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-18
The reference protocol establishes a standardized ex vivo whole-blood platform for testing how metabolic pathway inhibition changes immune-stimulus-induced cytokine production. Its main contribution is methodological: it preserves the cellular and soluble context of human blood while introducing controlled metabolic interventions suitable for reproducible immunometabolism research and cohort studies.
-
Triamcinolone: Protocol and QC Guide
2026-08-17
Triamcinolone is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, storage, assay controls, and troubleshooting; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical applications.
-
7-AAD Cell Viability Assay Kit Guide
2026-08-17
This scenario-based guide explains how the 7-AAD Cell Viability Assay Kit, SKU K2235, supports membrane-integrity measurements in flow cytometry, microscopy, and multiplex apoptosis workflows. It connects assay design, controls, storage, interpretation, and vendor-selection considerations to practical biomedical research needs.
-
hiPSC Differentiation into Corneal Endothelial Cells
2026-08-16
This study developed a two-step, chemically defined, serum-free workflow that directs human induced pluripotent stem cells through a neural crest intermediate toward corneal endothelial cell-like cells. Its combination of TGF-β and Wnt pathway modulation with staged marker validation provides a reproducible foundation for investigating cell-based approaches to corneal endothelial dysfunction.
-
Cholecystokinin octapeptide ammonium Guide
2026-08-15
This scenario-based guide explains how Cholecystokinin octapeptide ammonium (SKU C8717) can be incorporated into receptor-focused cell viability, apoptosis, immune-response, and neurobehavioral workflows. It emphasizes identity control, concentration selection, solubility limitations, and interpretation of context-dependent results.
-
Copper Single-Atom MOF for Ultrasound-Enhanced Therapy
2026-08-14
The reference study develops FA-NH2-UiO-66-Cu, a copper single-atom nanozyme that combines glutathione depletion, peroxidase-like hydroxyl radical generation, folate-associated targeting, and ultrasound activation. Its NIR-II imaging component provides a way to track tumor-associated distribution while ultrasound improves catalytic output, offering a coordinated platform for image-informed chemodynamic therapy.
-
PGE2–Schwann Cell Dedifferentiation in PDAC PNI
2026-08-14
Wang et al. identify a paracrine PTGES–PGE2 axis through which pancreatic ductal adenocarcinoma cells induce Schwann cell dedifferentiation and a proinvasive neural microenvironment. By combining spatial and single-cell analyses with coculture and three-dimensional perturbation models, the study links PGE2-stimulated Schwann cells to LIF- and ADAMTS-1-dependent remodeling associated with perineural invasion.
-
Proteinase K Workflows for DNA and Fungal EV Research
2026-08-13
Proteinase K combines broad protein digestion with compatibility across DNA extraction and extracellular-vesicle assay workflows. This guide translates its biochemical profile into practical protocols for genomic DNA isolation, enzyme contaminant removal, and mechanistic testing of Candida albicans EV cargo.